China SXT Pharmaceuticals, Inc. (SXTC) vs cbdMD, Inc. (YCBD)
China SXT Pharmaceuticals, Inc. and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. cbdMD, Inc. is the larger, with a market value of $4.8M against $3.5M — 1.4× the size. China SXT Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; cbdMD, Inc. trades at 55.3×. cbdMD, Inc. grew revenue faster over the last twelve months: 10.0% against −54.0%. cbdMD, Inc. has the higher net margin (−14.7% vs −255.2%) and the lower return on invested capital (−29.8% vs 0.00%). Across the 16 metrics below, China SXT Pharmaceuticals, Inc. leads on 10 and cbdMD, Inc. on 6.
Valuation
Profitability
| Metric | SXTC | YCBD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 36.69% | 57.68% | 53.94% |
| Operating margin | 0.00% | (13.87%) | 0.00% |
| Net margin | (255.16%) | (14.71%) | 0.00% |
| Free cash flow margin | 0.00% | (11.51%) | 0.00% |
| Return on equity | 0.00% | (43.01%) | (0.40%) |
| Return on assets | 0.00% | (26.73%) | (3.32%) |
| Return on invested capital | 0.00% | (29.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack